Bridgefront Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-632
Closed -$210K 764
2024
Q4
$210K Buy
+632
New +$214K 0.07% 481
2023
Q3
Sell
-1,906
Closed -$458K 526
2023
Q2
$458K Buy
+1,906
New +$396K 0.25% 134
2022
Q4
Sell
-2,316
Closed -$364K 457
2022
Q3
$364K Buy
2,316
+822
+55% +$131K 0.37% 92
2022
Q2
$224K Buy
+1,494
New +$216K 0.25% 199

Other funds holding MEDP

Bridgefront Capital's MEDP Position: Q1 2025 in Review

Bridgefront Capital sold out of Medpace (MEDP) in Q1 2025, closing a stake of 632 shares — an estimated $210K sold.

Bridgefront Capital first reported a position in MEDP in Q2 2022 and held it in 4 quarters. The position peaked at $458K in Q2 2023. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Bridgefront Capital reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
  • Bridgefront Capital sold 632 Medpace shares in Q1 2025, an estimated $210K.
  • Bridgefront Capital first reported a position in Medpace in Q2 2022 and held it in 4 quarters.
  • Bridgefront Capital's Medpace position peaked at $458K in Q2 2023.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Bridgefront Capital's 13F filing for Q1 2025, filed 15 May 2025.